Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leonard B Saltz, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mhat "dr. Tota Venkova"
Gabrovo, Bulgaria
- Interdistrict Dispensary in Oncology Diseases With Stationary-Ruse, Eood
Rousse, Bulgaria
- Interdistrict Dispensary in Oncology Diseases With Stationary
Shumen, Bulgaria
- Multiprofile Hospital for Active Treatment "tsaritza Joanna"
Sofia, Bulgaria
- Specialized Hospital for Active Treatment for Oncology
Sofia, Bulgaria
- Interdistrict Dispensary of Oncology Diseases With Stationary
Varna, Bulgaria
- Multiprofile Hospital for Active Treatment "sv. Marina", Ead,
Varna, Bulgaria
- Regional Cancer Centre, Indira Gandhi Institute of Medical Sciences
Sheikhpura, Patna, Bihar, India
- Cancer Clinic
Nagpur, Maharashtra, India
- Curie Manavata Cancer Centre, Opp.
Nashik, Maharashtra, India
- Deenanath Mangeshkar Hospital and Research Centre
Pune, Maharashtra, India
- Ruby Hall Clinic
Pune, Maharashtra, India
- G. Kuppuswamy Naidu Memorial Hospital
Pappanaickenpalayam, Coimbatore, Tamil Nadu, India
- Hospital Almanzor Aguinaga Asenjo - Chiclayo
Chiclayo, Peru
- Clinica Ricardo Palma
Lima, Peru
- Hospital Regional Nivel Iii Cayetano Heredia Essalud Piura
Piura, Peru
- Ponce School of Medicine/caimed Center
Ponce, Puerto Rico
- Fundacion de Investigacion de Diego
Santurce, Puerto Rico
- "prof. Dr. Ion Chiricuţă" Institute of Oncology
Cluj-Napoca, Romania
- Clinical Emergency Hospital - Oncology Department
Constanța, Romania
- Oncolab Srl, No. 1
Craiova, Romania
- Center of Medical Oncology
Iași, Romania
- Clinical Hospital Pelican Oradea
Oradea, Romania
- No. 1 City Hospital
Ploieşti, Romania
- "sf. Ioan Cel Nou" Clinical Emergency County Hospital
Suceava, Romania
- Clinic of Oncology - Radiotherapy
Tg. Mures, Romania
- the Cancer Center of Huntsville, Pc
Huntsville, Alabama, United States
- University of South Florida
Tampa, Florida, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Signal Point Clinical Research Center
Middletown, Ohio, United States
- Joe Arrington Cancer Research and Treatment Center
Lubbock, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 31 May 2012
- Completion
- 31 Mar 2013
- Last update posted
- 8 Jul 2015
- Registered enrollment
- 171
- Registry id
- NCT00890305
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.